Lotronex (Alosetron Hydrochloride) - RxList Monographs[rate it][review it] Description with links to full prescribing information for this 5-HT antagonist used for severe diarrhea-predominant irritable bowel syndrome (IBS). Removed from the US market in 2000 it was re-released in 2002 with more stringent labeling including a boxed warning.
Lotronex Information - FDA[rate it][review it] Includes information for patients and care givers with links to current (re-released)product information and information about the previous withdrawal from the market in 2000.